Viewing Study NCT04945733

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:45 AM

Ignite Modification Date: 2025-12-31 @ 1:46 AM

Study NCT ID: NCT04945733

Status: TERMINATED

Last Update Posted: 2024-09-19

First Post: 2021-06-23

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer

Sponsor: Janssen Pharmaceutical K.K.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module